Comparison of epidemiological factors between serous and mucinous borderline ovarian tumors: Therapeutic implications;Comparaison des facteurs épidémiologiques des tumeurs frontières séreuses et mucineuses de l'ovaire: Implications thérapeutiques

Bulletin du Cancer

Volumn 99, Issue 5, 2012, Pages 551-556

  Fauvet, Raffaèle ^a   Demblocque, Élodie ^a   Morice, Philippe ^b   Querleu, Denis ^c   Gondry, Jean ^a   Daraï, Émile ^d  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c INSTITUT CLAUDIUS REGAUD   (France)

^d HÔPITAL TENON   (France)

Author keywords

Borderline ovarian tumor; Epidemiology; Infertility; Intraepithelial carcinoma; Micropapillary pattern

Indexed keywords

ADULT; CANCER INVASION; CANCER STAGING; COMPARATIVE STUDY; EPIDEMIOLOGICAL DATA; FEMALE; FEMALE INFERTILITY; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAEPITHELIAL CARCINOMA; MAJOR CLINICAL STUDY; MUCINOUS BORDERLINE OVARIAN TUMOR; OVARY CARCINOMA; OVARY TUMOR; PERITONEUM; REVIEW; SEROUS BORDERLINE OVARIAN TUMOR;

EID: 84861445816     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2012.1570     Document Type: Article

References (44)

1. Taylor HJ. Malignant and semi-malignant tumours of the ovary. Surg Gynecol Obstet 1929; 48 : 204-30.
2. Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand 1971; 50 : 1-7.
3. Scully RE. World Health Organization classification and nomenclature of ovarian cancer. Natl Cancer Inst Monogr 1975; 42 : 5-7.
4. Prat J. Ovarian tumors of borderline malignancy (tumors of low malignant potential): a critical appraisal. Adv Anat Pathol 1999; 6 : 247-74.
5. Acs G. Serous and mucinous borderline (low malignant potential) tumors of the ovary. Am J Clin Pathol 2005; 123 (Suppl.) : S13-57.
6. Hart WR. Borderline epithelial tumors of the ovary. Mod Pathol 2005; 18 (Suppl. 2) : S33-50. (Pubitemid 40188616)
7. Gotlieb WH, Chetrit A, Menczer J, et al. Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer. Gynecol Oncol 2005; 97 : 780-3. (Pubitemid 40824646)
8. Eltabbakh GH, Natarajan N, Piver MS, Mettlin CJ. Epidemiologic differences between women with borderline ovarian tumors and women with epithelial ovarian cancer. Gynecol Oncol 1999; 74 : 103-7. (Pubitemid 29331175)
9. Hannibal CG, Huusom LD, Kjaerbye-Thygesen A, Tabor A, Kjaer SK. Trends in incidence of borderline ovarian tumors in Denmark 1978-2006. Acta Obstet Gynecol Scand 2011; 90 : 305-12.
10. Lalwani N, Shanbhogue AK, Vikram R, Nagar A, Jagirdar J, Prasad SR. Current update on borderline ovarian neoplasms. AJR Am J Roentgenol 2010; 194 : 330-6.
11. Cadron I, Amant F, Van Gorp T, Neven P, Leunen K, Vergote I. The management of borderline tumours of the ovary. Curr Opin Oncol 2006; 18 : 488-93. (Pubitemid 44199846)
12. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 1996; 20 : 1319-30. (Pubitemid 26367203)
13. Ronnett BM, Kajdacsy-Balla A, Gilks CB, et al. Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior. Hum Pathol 2004; 35 : 949-60. (Pubitemid 39037178)
14. Tavassoli FA, Devilee P.World Health Organization classification of tumors: pathology and genetics of tumors of the breast and female genital organs. Lyon, France : IARC Press, 2003.
15. FIGO (International Federation of Gynecology and Obstetrics) 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2006; 95 (Suppl. 1) : S1-257.
16. Shih KK, Zhou Q, Huh J, et al. Risk factors for recurrence of ovarian borderline tumors. Gynecol Oncol 2011; 120 : 480-4.
17. Shi Y, Ye D, Lu W, Zhao C, Xu J, Chen L. Histological classification in 10288 cases of ovarian malignant tumors in China. Zhonghua Fu Chan Ke Za Zhi 2002; 37 : 97-100.
18. Nakashima N, Nagasaka T, Oiwa N, et al. Ovarian epithelial tumors of borderline malignancy in Japan. Gynecol Oncol 1990; 38 : 90-8. (Pubitemid 20206232)
19. Thanikasalam K, Ho CM, Adeed N, Shahidan MN, Azizah WK. Pattern of ovarian tumours among Malaysian women at General Hospital, Kuala Lumpur. Med J Malaysia 1992; 47 : 139-46.
20. Saygili U, Uslu T, Erten O, Dogan E. Borderline ovarian tumours: retrospective analysis of twenty-one cases. Eur J Gynaecol Oncol 1998; 19 : 182-5. (Pubitemid 28171311)
21. Lindgren PR, Backstrom T, Cajander S, et al. The pattern of estradiol and progesterone differs in serum and tissue of benign and malignant ovarian tumors. Int J Oncol 2002; 21 : 583-9.
22. Swanton A, Bankhead CR, Kehoe S. Pregnancy rates after conservative treatment for borderline ovarian tumours: a systematic review. Eur J Obstet Gynecol Reprod Biol 2007; 135 : 3-7. (Pubitemid 350026161)
23. Chang SJ, Ryu HS, Chang KH, Yoo SC, Yoon JH. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors. Acta Obstet Gynecol Scand 2008; 87 : 476-81.
24. Grimley PM, Matsuno RK, Rosenberg PS, Henson DE, Schwartz AM, Anderson WF. Qualitative age interactions between low-grade and high-grade serous ovarian carcinomas. Cancer Epidemiol Biomarkers Prev 2009; 18 : 2256-61.
25. Kurman RJ, Seidman JD, Shih IM. Serous borderline tumours of the ovary. Histopathology 2005; 47 : 310-5.
26. Kurman RJ, Shih Ie M. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 2008; 27 : 151-60. (Pubitemid 351450677)
27. Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 2000; 31 : 539-57. (Pubitemid 30323979)
28. Laurent I, Uzan C, Gouy S, Pautier P, Duvillard P, Morice P. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern. Ann Surg Oncol 2008; 15 : 3561-6.
29. Fauvet R, Demblocque E, Morice P, Querleu D, Daraï E. Behavior of serous borderline ovarian tumors with and without micropapillary patterns: results of a French multicenter study. Ann Surg Oncol 2012; 19 : 941-7.
30. Kane A, Uzan C, Rey A, et al. Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants. Oncologist 2009; 14 : 591-600.
31. Hart WR, Norris HJ. Borderline and malignant mucinous tumors of the ovary. Histologic criteria and clinical behavior. Cancer 1973; 31 : 1031-45.
32. Segal GH, Hart WR. Ovarian serous tumors of low malignant potential (serous borderline tumors). The relationship of exophytic surface tumor to peritoneal "implants". Am J Surg Pathol 1992; 16 : 577-83.
33. Harris R, Whittemore AS, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992; 136 : 1204-11. (Pubitemid 23026891)
34. Mosgaard BJ, Lidegaard O, Kjaer SK, Schou G, Andersen AN. Ovarian stimulation and borderline ovarian tumors: a case-control study. Fertil Steril 1998; 70 : 1049-55. (Pubitemid 28546230)
35. Ness RB, Cramer DW, Goodman MT, et al. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 2002; 155 : 217-24. (Pubitemid 34117299)
36. Parazzini F, Negri E, La Vecchia C, et al. Treatment for fertility and risk of ovarian tumors of borderline malignancy. Gynecol Oncol 1998; 68 : 226-8. (Pubitemid 28183489)
37. Rossing MA, Tang MT, Flagg EW, Weiss LK, Wicklund KG. A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs. Am J Epidemiol 2004; 160 : 1070-8. (Pubitemid 39557459)
38. Shushan A, Paltiel O, Schenker JG. Induction of ovulation and borderline ovarian cancer-the hormonal connection? Eur J Obstet Gynecol Reprod Biol 1999; 85 : 71-4. (Pubitemid 29248786)
39. Brzakowski M, Lourdel E, Cabry R, et al. Épidémiologie du couple infertile. J Gynecol Obstet Biol Reprod (Paris) 2009 ; 38 (Spec No 1-2) : F3-7.
40. Palomba S, Zupi E, Russo T, et al. Comparison of two fertilitysparing approaches for bilateral borderline ovarian tumours: a randomized controlled study. Hum Reprod 2007; 22 : 578-85. (Pubitemid 46152583)
41. van Niekerk CC, Bulten J, van Dijck JA, Verbeek AL. Epithelial ovarian carcinoma types and the coexistence of ovarian tumor conditions. Obstet Gynecol 2011 ; 2011 : 784919.
42. Scully RE. Early de novo ovarian cancer and cancer developing in benign ovarian lesions. Int J Gynaecol Obstet 1995; 49 (Suppl.) : S9-15.
43. Khunamornpong S, Settakorn J, Sukpan K, Suprasert P, Siriaunkgul S. Mucinous tumor of low malignant potential ("borderline" or "atypical proliferative" tumor) of the ovary: a study of 171 cases with the assessment of intraepithelial carcinoma and microinvasion. Int J Gynecol Pathol 2011; 30 : 218-30.
44. Silverberg SG, Bell DA, Kurman RJ, et al. Borderline ovarian tumors: key points and workshop summary. Hum Pathol 2004; 35 : 910-7. (Pubitemid 39037175)